GLP-1 receptor agonists (semaglutide, tirzepatide, and the next generation behind them) shift glucose, lipids, inflammation, kidney function, and liver enzymes
Tighter pack-outs also keep gel packs in close contact with the medication, improving cooling
Not available in AL, AR, CA, NV, LA, MS & DC
Future of transdermal GLP-1 delivery Research on true pharmaceutical-grade transdermal GLP-1 delivery is underway: Microneedle array patches : Use tiny dissolvable needles to deliver medication just below the skin Enhanced transdermal systems : Employ special technologies to improve skin penetration Controlled-release formulations : Designed for sustained delivery over days or weeks Animal studies have shown promising results, with some experimental patches achieving blood levels comparable to those of injections
Nature Medicine, 2024 Jan5;30(1):168176